[SCHEDULE 13D/A CUSIP No. 88674Y 105 Page 2 of 8 1. Names of reporting persons MOJICA LIMITED 2. Check the appropriate box if a member of a group (see instructions) x ¨ (a) 3. SEC use only 4. Source of funds (see instructions) OO 5. ¨ 6. Citizenship or place of organization British Virgin Islands Number of shares beneficially owned]
[THIRD AMENDED AND RESTATED JOINT FILING AGREEMENT FROST GAMMA INVESTMENTS TRUST Phillip Frost, M.D. Sole Trustee Phillip Frost, M.D., individually EX-99.9 2 d903780dex999.htm EX-99.9] [CUSIP No. 88674Y 105 Page 2 of 6 1. Names of reporting persons Phillip Frost, M.D. 2. Check the appropriate box if a member of a group (see instructions) x ¨ (a) 3. SEC use only 4. Source of funds (see instructions) N/A 5. ¨ 6. Citizenship or place of organization Number of shares beneficially owned by each reporting person]
[THIRD AMENDED AND RESTATED JOINT FILING AGREEMENT FROST GAMMA INVESTMENTS TRUST Phillip Frost, M.D. Sole Trustee Phillip Frost, M.D., individually EX-99.9 2 d903780dex999.htm EX-99.9] [CUSIP No. 88674Y 105 Page 2 of 6 1. Names of reporting persons Phillip Frost, M.D. 2. Check the appropriate box if a member of a group (see instructions) x ¨ (a) 3. SEC use only 4. Source of funds (see instructions) N/A 5. ¨ 6. Citizenship or place of organization Number of shares beneficially owned by each reporting person]
[HANWHA Q CELLS ANNOUNCES SHAREHOLDER RESOLUTION ADOPTED AT EGM Company Hanwha Q CELLS SEOUL, SOUTH KOREA April 6, 2015 Hanwha Q CELLS Co., Ltd. (the AOA About Hanwha Q CELLS Safe-Harbor Statement Investor Relations For further information, please contact: Hanwha Q CELLS: Paul Combs V.P. of Investor Relations Hanwha Building 9F 86 Cheonggyecheon-ro Jung-gu, Seoul, Korea] [Hanwha Q CELLS Co., Ltd. Seong Woo Nam Chairman and CEO 6-K 1 d902596d6k.htm FORM 6-K]
